Clinical Trial Update: Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dupilumab in Chinese patients with atopic dermatitis has completed, focusing on skin barrier function and lipidomics. The sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis, Dermatitis Atopic | Phase 4 | Status: COMPLETED